These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3302880)

  • 1. [Clinical study and effect of nitroxoline on fecal flora in children].
    Lambert-Zechovsky N; Lévêque B; Bingen E; Pillion G; Chapelle J; Mathieu H
    Pathol Biol (Paris); 1987 May; 35(5):669-72. PubMed ID: 3302880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline].
    Karam D; Amgar A; Bourlioux P
    Pathol Biol (Paris); 1988 May; 36(5):452-5. PubMed ID: 3043342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antifungal activity of nitroxoline. Preliminary clinical results].
    Cancet B; Amgar A
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):879-81. PubMed ID: 3309833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Direct effect of nitroxoline in the inhibition of bacterial adherence to urinary catheters].
    Oliviero L; Perdiz M; Bourlioux P
    Pathol Biol (Paris); 1990 May; 38(5):455-8. PubMed ID: 2195455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity in vitro of urine samples from patients treated by nitroxoline against mycoplasmas.
    Amgar A; Bonissol C; Stoiljkovic B
    J Chemother; 1989 Jul; 1(4 Suppl):226-8. PubMed ID: 16312380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibition of bacterial adherence by nitroxoline on cellular adhesion and on urinary catheter surfaces].
    Bourlioux P; Botto H; Karam D; Amgar A; Camey M
    Pathol Biol (Paris); 1989 May; 37(5):451-4. PubMed ID: 2674871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections.
    Naber KG; Niggemann H; Stein G; Stein G
    BMC Infect Dis; 2014 Nov; 14():628. PubMed ID: 25427651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological consequences of chelation of bivalent metal cations by nitroxoline].
    Pelletier C; Prognon P; Latrache H; Villart L; Bourlioux P
    Pathol Biol (Paris); 1994 May; 42(5):406-11. PubMed ID: 7824304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid.
    Careddu P; Borzani M; Scotti L; Varotto F; Garlaschi L; Fontana P
    Chemioterapia; 1987 Aug; 6(4):290-4. PubMed ID: 3652281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S
    Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is nitroxoline an allergen?].
    Rodor F; Castelain M; Prost N; Galland MC; Nguyen N; Benjelloun R; Valli M; Jean-Pastor MJ
    Therapie; 2002; 57(2):204-5. PubMed ID: 12185975
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria.
    Abouelhassan Y; Yang Q; Yousaf H; Nguyen MT; Rolfe M; Schultz GS; Huigens RW
    Int J Antimicrob Agents; 2017 Feb; 49(2):247-251. PubMed ID: 28110918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.
    Christiaens TC; De Meyere M; Verschraegen G; Peersman W; Heytens S; De Maeseneer JM
    Br J Gen Pract; 2002 Sep; 52(482):729-34. PubMed ID: 12236276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High sensitivity of Escherichia coli to antimicrobial agents used for first-line treatment of urinary tract infections; results of an examination of feces of healthy subjects in Friesland].
    Overbeek BP; Overdijk CJ; Dikhoff JH; Goetsch WG
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):688-91. PubMed ID: 11530707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of cefoperazone on the fecal flora in children].
    Lambert-Zechovsky N; Bingen E; Proux MC; Aujard Y; Mathieu H
    Pathol Biol (Paris); 1984 May; 32(5):439-42. PubMed ID: 6739153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of nitroxoline on urogenital mycoplasmas].
    Bonissol C; Pua K; Stoïljkovic B
    Pathol Biol (Paris); 1986 Nov; 34(9):1001-5. PubMed ID: 3543811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment trials in urinary tract infection (UTI) with special reference to the effect of antimicrobials on the fecal and periurethral flora.
    Winberg J; Bergström T; Lincoln K; Lidin-Janson G
    Clin Nephrol; 1973; 1(3):142-8. PubMed ID: 4593447
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the treatment of candiduria and nitroxoline sensitivity of Candida isolates].
    Vahlensieck W
    Urologe A; 2017 May; 56(5):658. PubMed ID: 28424828
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present status of nitroxoline].
    Bergogne-Berezin E; Berthelot G; Muller-Serieys C
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):873-8. PubMed ID: 3309832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.